Neurocrine Biosciences Inc. (NBIX) News Nov 20, 20
Post# of 250601
Posted On: 11/20/2014 10:35:41 PM
Neurocrine Biosciences Inc. (NBIX) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on NBIX
Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois
Stock futures gain as S&P 500 looks to halt skid 8:59 a.m. Jan. 7, 2014 - Victor Reklaitis
Yahoo, Palo Alto, Neurocrine are stocks to watch 5:31 a.m. Jan. 7, 2014 - Wallace Witkowski
Palo Alto, Convergys shares rise on acquisitions 5:08 p.m. Jan. 6, 2014 - Wallace Witkowski
Neurocrine Biosciences shares jump 60% on study 4:51 p.m. Jan. 6, 2014 - Wallace Witkowski
Neurocrine Biosciences shares surge on study 4:50 p.m. Jan. 6, 2014 - MarketWatch.com
S&P’s 50-day average remains the technical test 10:10 a.m. July 1, 2013 - Michael Ashbaugh
Volatility spike supports bullish market view 11:07 a.m. June 4, 2013 - Michael Ashbaugh
Volatility spike supports bullish market view 10:59 a.m. June 4, 2013 - Michael Ashbaugh
In focus: Bears trying to gain traction 6:30 p.m. May 29, 2013 - Lawrence G. McMillan
In focus: Awaiting the next move 7:57 p.m. Feb. 6, 2013 - Lawrence G. McMillan
Neurocrine to offer 9.5 mln shares 10:02 a.m. Jan. 19, 2012 - MarketWatch.com
Inspire, Questcor lead drug stocks north 2:55 p.m. April 5, 2011 - Val Brickates Kennedy
Neurocrine climbs on drug update 10:50 a.m. April 5, 2011 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:31 p.m. Feb. 11, 2011 - Kate Gibson
Mannkind sinks in mixed drug sector 3:20 p.m. Feb. 11, 2011 - Val Brickates Kennedy
Drug stocks inch higher; Cytori slides 2:34 p.m. Oct. 8, 2010 - Val Brickates Kennedy
Neurocrine shares jump on analyst rating 9:07 a.m. Oct. 8, 2010 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:26 p.m. Sept. 15, 2010 - MarketWatch
Neurocrine Biosciences shares up 4% 8:33 a.m. June 17, 2010 - Nick Godt
Other News on NBIX
5 Stocks With Crummy Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 4:15 a.m. Nov. 17, 2014 - InvestorPlace.com
5 Stocks With Bad Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 1:45 a.m. Nov. 10, 2014 - InvestorPlace.com
Neurocrine Biosciences Looking Forward To A Big Year 11:57 a.m. Nov. 6, 2014 - Seeking Alpha
10-Q: NEUROCRINE BIOSCIENCES INC 1:00 p.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Neurocrine Biosciences' (NBIX) CEO Kevin Gorman on Q3 2014 Results - Earnings Call Transcript 12:09 a.m. Nov. 4, 2014 - Seeking Alpha
5 Stocks With Awful Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 2:30 a.m. Nov. 3, 2014 - InvestorPlace.com
Notable earnings after Monday’s close 5:35 p.m. Nov. 2, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – SGEN NBIX LGND ACHC 8:00 a.m. Oct. 31, 2014 - InvestorPlace.com
5 Stocks With Bad Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 4:30 a.m. Oct. 27, 2014 - InvestorPlace.com
End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies 7:40 a.m. Oct. 20, 2014 - Seeking Alpha
5 Stocks With Crummy Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 4:45 a.m. Oct. 20, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – HCA NKTR THC NBIX 1:30 p.m. Oct. 16, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – HTWR CLDX PTCT NBIX 7:45 a.m. Oct. 14, 2014 - InvestorPlace.com
5 Stocks With Bad Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 5:15 a.m. Oct. 13, 2014 - InvestorPlace.com
KVB Capital LLC's Best And Worst Third-Quarter Performers 2:42 p.m. Oct. 10, 2014 - Seeking Alpha
5 Stocks With Crummy Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 5:15 a.m. Oct. 6, 2014 - InvestorPlace.com
Neurocrine Initiates Tourette Syndrome Clinical Trial 3:03 p.m. Oct. 2, 2014 - benzinga.com
5 Stocks With Poor Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 3:45 a.m. Sept. 29, 2014 - InvestorPlace.com
5 Stocks With Crummy Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 3:45 a.m. Sept. 22, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – VRTX IRWD NBIX ACOR 1:15 p.m. Sept. 18, 2014 - InvestorPlace.com
Press Releases on NBIX
Retrophin Names Margaret Valeur-Jensen, Ph.D. as General Counsel 8:01 a.m. Nov. 19, 2014 - BusinessWire - BZX
Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference 1:56 p.m. Nov. 12, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference 1:00 p.m. Nov. 12, 2014 - PR Newswire - PRF
Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer 7:30 a.m. Nov. 4, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the Nomura Biotechnology Conference 7:00 p.m. Nov. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Reports Third Quarter 2014 Results 4:01 p.m. Nov. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia 6:30 a.m. Oct. 30, 2014 - PR Newswire - PRF
Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2014 Financial Results 3:05 p.m. Oct. 27, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854 3:05 p.m. Oct. 20, 2014 - PR Newswire - PRF
Neurocrine Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study 3:02 p.m. Oct. 2, 2014 - PR Newswire - PRF
Neurocrine Biosciences, Inc. Announces Appointment of Malcolm Lloyd-Smith as Chief Regulatory Officer 4:20 p.m. Oct. 1, 2014 - PR Newswire - PRF
Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference 12:00 p.m. Sept. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Reports Second Quarter 2014 Results 3:02 p.m. Aug. 6, 2014 - PR Newswire - PRF
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 7:40 a.m. July 31, 2014 - PR Newswire - PRF
Critical Alerts For Silicon Motion Technology, Pharmacyclics, 3D Systems, Walgreen, and Neurocrine Biosciences Released By InvestorsObserver 8:31 a.m. July 30, 2014 - PR Newswire - PRF
Global Women%s Health Market 2014-2018 5:20 p.m. July 28, 2014 - PR Newswire - PRF
Insomnia Global Clinical Trials Review, H2, 2014 12:14 p.m. July 23, 2014 - PR Newswire - PRF
Neurocrine Biosciences Presenting NBI-98854 Scientific Abstracts And Posters At The International Parkinson And Movement Disorder Society's 18th Annual Congress 6:00 a.m. June 11, 2014 - PR Newswire - PRF
Health Care Sector Equities Coverage -- Research on Neurocrine Biosciences, PDL BioPharma, Celgene, and Array BioPharma 6:50 a.m. June 6, 2014 - PR Newswire - PRF
MarketWatch News on NBIX
Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois
Stock futures gain as S&P 500 looks to halt skid 8:59 a.m. Jan. 7, 2014 - Victor Reklaitis
Yahoo, Palo Alto, Neurocrine are stocks to watch 5:31 a.m. Jan. 7, 2014 - Wallace Witkowski
Palo Alto, Convergys shares rise on acquisitions 5:08 p.m. Jan. 6, 2014 - Wallace Witkowski
Neurocrine Biosciences shares jump 60% on study 4:51 p.m. Jan. 6, 2014 - Wallace Witkowski
Neurocrine Biosciences shares surge on study 4:50 p.m. Jan. 6, 2014 - MarketWatch.com
S&P’s 50-day average remains the technical test 10:10 a.m. July 1, 2013 - Michael Ashbaugh
Volatility spike supports bullish market view 11:07 a.m. June 4, 2013 - Michael Ashbaugh
Volatility spike supports bullish market view 10:59 a.m. June 4, 2013 - Michael Ashbaugh
In focus: Bears trying to gain traction 6:30 p.m. May 29, 2013 - Lawrence G. McMillan
In focus: Awaiting the next move 7:57 p.m. Feb. 6, 2013 - Lawrence G. McMillan
Neurocrine to offer 9.5 mln shares 10:02 a.m. Jan. 19, 2012 - MarketWatch.com
Inspire, Questcor lead drug stocks north 2:55 p.m. April 5, 2011 - Val Brickates Kennedy
Neurocrine climbs on drug update 10:50 a.m. April 5, 2011 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:31 p.m. Feb. 11, 2011 - Kate Gibson
Mannkind sinks in mixed drug sector 3:20 p.m. Feb. 11, 2011 - Val Brickates Kennedy
Drug stocks inch higher; Cytori slides 2:34 p.m. Oct. 8, 2010 - Val Brickates Kennedy
Neurocrine shares jump on analyst rating 9:07 a.m. Oct. 8, 2010 - Val Brickates Kennedy
Wednesday’s biggest gaining and declining stocks 4:26 p.m. Sept. 15, 2010 - MarketWatch
Neurocrine Biosciences shares up 4% 8:33 a.m. June 17, 2010 - Nick Godt
Other News on NBIX
5 Stocks With Crummy Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 4:15 a.m. Nov. 17, 2014 - InvestorPlace.com
5 Stocks With Bad Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 1:45 a.m. Nov. 10, 2014 - InvestorPlace.com
Neurocrine Biosciences Looking Forward To A Big Year 11:57 a.m. Nov. 6, 2014 - Seeking Alpha
10-Q: NEUROCRINE BIOSCIENCES INC 1:00 p.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Neurocrine Biosciences' (NBIX) CEO Kevin Gorman on Q3 2014 Results - Earnings Call Transcript 12:09 a.m. Nov. 4, 2014 - Seeking Alpha
5 Stocks With Awful Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 2:30 a.m. Nov. 3, 2014 - InvestorPlace.com
Notable earnings after Monday’s close 5:35 p.m. Nov. 2, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – SGEN NBIX LGND ACHC 8:00 a.m. Oct. 31, 2014 - InvestorPlace.com
5 Stocks With Bad Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 4:30 a.m. Oct. 27, 2014 - InvestorPlace.com
End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies 7:40 a.m. Oct. 20, 2014 - Seeking Alpha
5 Stocks With Crummy Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 4:45 a.m. Oct. 20, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – HCA NKTR THC NBIX 1:30 p.m. Oct. 16, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – HTWR CLDX PTCT NBIX 7:45 a.m. Oct. 14, 2014 - InvestorPlace.com
5 Stocks With Bad Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 5:15 a.m. Oct. 13, 2014 - InvestorPlace.com
KVB Capital LLC's Best And Worst Third-Quarter Performers 2:42 p.m. Oct. 10, 2014 - Seeking Alpha
5 Stocks With Crummy Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 5:15 a.m. Oct. 6, 2014 - InvestorPlace.com
Neurocrine Initiates Tourette Syndrome Clinical Trial 3:03 p.m. Oct. 2, 2014 - benzinga.com
5 Stocks With Poor Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 3:45 a.m. Sept. 29, 2014 - InvestorPlace.com
5 Stocks With Crummy Operating Margin Growth — NBIX CTEL TSRA NYNY PMFG 3:45 a.m. Sept. 22, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – VRTX IRWD NBIX ACOR 1:15 p.m. Sept. 18, 2014 - InvestorPlace.com
Press Releases on NBIX
Retrophin Names Margaret Valeur-Jensen, Ph.D. as General Counsel 8:01 a.m. Nov. 19, 2014 - BusinessWire - BZX
Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference 1:56 p.m. Nov. 12, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference 1:00 p.m. Nov. 12, 2014 - PR Newswire - PRF
Neurocrine Biosciences, Inc. Announces Appointment of Darin Lippoldt as Chief Legal Officer 7:30 a.m. Nov. 4, 2014 - PR Newswire - PRF
Neurocrine Biosciences to Present at the Nomura Biotechnology Conference 7:00 p.m. Nov. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Reports Third Quarter 2014 Results 4:01 p.m. Nov. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia 6:30 a.m. Oct. 30, 2014 - PR Newswire - PRF
Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2014 Financial Results 3:05 p.m. Oct. 27, 2014 - PR Newswire - PRF
Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 7:35 a.m. Oct. 27, 2014 - PR Newswire - PRF
Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854 3:05 p.m. Oct. 20, 2014 - PR Newswire - PRF
Neurocrine Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study 3:02 p.m. Oct. 2, 2014 - PR Newswire - PRF
Neurocrine Biosciences, Inc. Announces Appointment of Malcolm Lloyd-Smith as Chief Regulatory Officer 4:20 p.m. Oct. 1, 2014 - PR Newswire - PRF
Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference 12:00 p.m. Sept. 3, 2014 - PR Newswire - PRF
Neurocrine Biosciences Reports Second Quarter 2014 Results 3:02 p.m. Aug. 6, 2014 - PR Newswire - PRF
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 7:40 a.m. July 31, 2014 - PR Newswire - PRF
Critical Alerts For Silicon Motion Technology, Pharmacyclics, 3D Systems, Walgreen, and Neurocrine Biosciences Released By InvestorsObserver 8:31 a.m. July 30, 2014 - PR Newswire - PRF
Global Women%s Health Market 2014-2018 5:20 p.m. July 28, 2014 - PR Newswire - PRF
Insomnia Global Clinical Trials Review, H2, 2014 12:14 p.m. July 23, 2014 - PR Newswire - PRF
Neurocrine Biosciences Presenting NBI-98854 Scientific Abstracts And Posters At The International Parkinson And Movement Disorder Society's 18th Annual Congress 6:00 a.m. June 11, 2014 - PR Newswire - PRF
Health Care Sector Equities Coverage -- Research on Neurocrine Biosciences, PDL BioPharma, Celgene, and Array BioPharma 6:50 a.m. June 6, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼